Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Growth · Tanaka

TANAKA Growth Fund (TGFRX)

Ticker TGFRX · · Holdings as of May 31, 2026

Expense ratio
1.95%$195/yr per $10k
5-yr return
+19.4%annualized
1-yr return
+39.3%as of Dec 2025
Net assets
$39.7Mall share classes
Holdings
25

Bottom line

Is TGFRX a good fund? The bottom line

TGFRX is an actively managed large growth mutual fund from Tanaka.

Its expense ratio is 1.95% — about $195 a year on every $10,000 invested, more expensive than 97% of large growth funds we track.

It returned +39.3% over one year, +19.4% a year over five years, +12.8% a year over ten (as of Dec 31, 2025, per its prospectus).

With $39.7 million in net assets and 25 holdings, its largest position is Corcept Therapeutics, Inc. (9.1%) and the top 10 make up 58.5% of the portfolio.

What stands out

  • 5-year return beat 99% of category peers

What to watch

  • Expensive for its category (1.95%)
  • Concentrated: top 10 holdings are 58.5% of assets
  • 12b-1 marketing fee of 0.25% a year
  • Small fund ($39.7 million) — small funds are likelier to close

Updated Nov 19, 2026

What TGFRX invests in

The Fund's investment objective is growth of capital.

The Fund employs the following principal investment strategies: Normally investing in common stocks and other equity securities of small, medium and large capitalization companies. Investing up to 45% of its net assets, measured at the time of investment, in foreign securities, including multinational and emerging market securities. The Fund is a non-diversified fund, which means that the Fund may take larger positions in a small number of companies than a diversified fund. Investing in issues which the Fund's investment Advisor believes have superior capital growth potential. Companies that meet or exceed specific criteria established by the investment manager in the selection process are purchased. Securities are sold when they reach internally determined pricing targets or no longer qualify under the managers investment criteria. While the Fund usually will normally diversify its…

From the fund's prospectus (filed Mar 31, 2026).

TGFRX performance

Average annual total returns
1 yr5 yr10 yr
TGFRX+39.3%+19.4%+12.8%
Large Growth median+15.2%+11.0%+14.2%

Source: Fund prospectus, as of Dec 31, 2025

Full TGFRX performance history →

What TGFRX costs

On a $10,000 investment, TGFRX's 1.95% expense ratio costs about $195 a year. The prospectus estimates $2,275 in total costs over 10 years (assuming 5% annual returns). The median large growth fund charges 0.87%.

See the full TGFRX fee table →

TGFRX top 10 holdings

#Holding% of fund
1Corcept Therapeutics, Inc.9.14%
2NVIDIA Corp.7.41%
3United States Antimony Corp.7.34%
4Nuvation Bio, Inc.5.83%
5NexGen Energy Ltd.5.54%
6Aura Minerals, Inc.5.49%
7Apple, Inc.5.15%
8Intellia Therapeutics, Inc.4.39%
9Applied Materials, Inc.4.38%
10Electrovaya, Inc.3.82%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 58.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to TGFRX

More funds like TGFRX →

TGFRX FAQ

What is the expense ratio of TGFRX?
TGFRX's expense ratio is 1.95%, which works out to about $195 a year for every $10,000 invested. The prospectus estimates total costs of $2,275 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is TGFRX a good investment?
It depends on your goals, but the data points to: 5-year return beat 99% of category peers; expensive for its category (1.95%); concentrated: top 10 holdings are 58.5% of assets; 12b-1 marketing fee of 0.25% a year; small fund ($39.7 million) — small funds are likelier to close. This is general information, not personalized advice.
What does TGFRX hold?
TGFRX's largest holdings are Corcept Therapeutics, Inc. (9.1%), NVIDIA Corp. (7.4%), United States Antimony Corp. (7.3%), Nuvation Bio, Inc. (5.8%), NexGen Energy Ltd. (5.5%). It holds 25 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is TGFRX's 5-year return?
TGFRX returned +19.4% a year over the five years ending Dec 31, 2025, and +12.8% a year over ten years. Past performance does not guarantee future results.
Who manages TGFRX?
TGFRX is offered by Tanaka through Tanaka Funds Inc.